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Abstract 
The spirometry test is routinely performed to assess FEV1, FVC, and FEV1/FVC ratio among chronic obstructive pulmonary 
disease (COPD) patients with the increased activity of MMP-9. Saliva is less invasive to assess the MMP-9 activity. This study 
aimed to compare Pulmonary Function Tests to estimate the MMP-9 activity. The respondents were 30 COPD outpatients from 
Pulmonary Policlinic. Results showed mean ratio of FEV1, FVC, FEV1/FVC (SD) and that of the salivary MMP-9 activity were 
1.67 (0.12) L, 2.97 (0.43) L, 56.15 (8.43) % and 1.85 (1.54) PM respectively. The correlation between FEV1, FVC, and 
FEV1/FVC ratio and the salivary MMP-9 activity was insignificant (p>0.05). The pulmonary function tests were not able to 
estimate the salivary MMP-9 activity. The findings suggest further activities of MMP-9 from other samples for comparison of 
protease activity. 
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Nomenclature 
BAL  Broncho-alveolar lavage  
COPD  Chronic obstructive pulmonary disease  
ECM Extracellular matrix  
FEV1  Forced expiratory volume in 1 second  
FVC  Forced vital capacity  
GOLD  Global initiative for chronic obstructive lung disease  
MMP-9  Matrix metalloproteinase-9  
TIMP-1  Tissue inhibitor of metalloproteinase-1 
1. Introduction 
The prevalence of chronic obstructive pulmonary disease (COPD) in Indonesia has reached 4.8 millions of 
which 90% is smokers or former smokers. COPD is mainly triggered by smoke exposures and other dangerous 
agents like gases and chemical substances from the environment. The genetic inheritance, previous history of 
respiratory infection, intrauterine growth retardation (IUGR), poor nutrition, and low income also contribute to the 
increase of COPD. The passive smokers, approximately 20%, are also risky for getting COPD1,2. 
Spirometry is routinely performed by those complaining dyspnoe promptly, so that they may have the 
appropriate treatment subsequently. The calibrated spirometry is initially prepared before patients start the test. 
Then, the measurements of forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) are 
performed with acceptable maneuvers. The results are very beneficial to determine either obstruction, restriction, or 
mixed. Regarding the diagnosis of COPD, the baseline of GOLD 2013 is properly applied1,2,3. 
The increase of matrix metalloproteinase (MMP)-9 activity from plasma is correlated with ˞1-anti tripsin-related 
emphysema4,5. Moreover, the higher MMP-9 level is linear with the lower FEV1, transport of CO, and oxygen 
saturation. The increase of MMP-9 level might estimate the decline of pulmonary function and the risk of 
exacerbation. The cigarette consumption is also correlated with MMP-9 level4. Prior authors and colleagues have 
started numerous studies to determine the correlation between different biological biomarkers and the pulmonary 
function. For COPD, many biomarkers from broncho-alveolar lavage (BAL) fluid and sputum have been developed 
in order to generate precise relationships between types of biomarkers and pulmonary function. Types of biomarkers 
engaged in those studies were agents of oxidative stress, cytokines and various proteases describing the pathogenesis 
of COPD. However, how to get the respiratory samples should be considered as well as those body fluids which 
have not been easily obtained5,6,7,8. 
Since smoking would affect the pathological processes of oral cavity and lungs which induced inflammatory 
mediators releasing MMP-9, our study tried to utilize the saliva to assess the MMP-9 activity from the fluid in order 
to link the association between spirometry results and the activity of protease. Furthermore, hopefully, the 
spirometry tests might be correlated adequately to the salivary MMP-9 activity among COPD patients. 
2. Methods 
This study employed thirty (30) smoker outpatients with COPD who visited pulmonary policlinic of Dr. Zainoel 
Abidin General Hospital in Banda Aceh - Indonesia. The study applied cross sectional design to determine inclusion 
and exclusion criteria for those enrolled as respondents. In advance, they were confirmed as COPD patients based 
on spirometry results i.e. FEV1/FVC ratio <70% with mild, moderate, severe and very severe GOLD spirometric 
level3. Other criteria were: smokers, male, >50 years old, 20 pack years of cigarette consumption. The exclusion 
criteria were tuberculosis and malignancy. The study was officially approved by the Ethics Committee of Faculty of 
Medicine, Syiah Kuala University - Banda Aceh. All respondents had to sign the informed consents before 
undergoing the physical examination and saliva collection. 
The saliva was collected by spitting out the fluid into the sterile pot. Respondents who had shown the worst oral 
hygiene and bloody spittle discharge were excluded from the study. All collected saliva was stored in -80 0C freezer 
for subsequent analysis with Sensolytep 520 Generic MMP assay kit Fluorimetric. 
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3. Results and discussion 
3.1. Characteristics of respondents’ spirometry test and salivary MMP-9 activity 
This research employed 30 respondents who were diagnosed with COPD regardless GOLD obstruction criteria. 
The spirometry tests showed mean ratio of FEV1, FVC, and FEV1/FVC (SD) i.e. 1.67 (0.12) L, 2.97 (0.43) L and 
56.15 (8.43) % respectively. Moreover, the salivary MMP-9 activity was 1.85 (1.54) PM. Spirometry results showed 
that FEV1/FVC ratio was <70% confirming that respondents suffered from COPD. Data were shown in Table 1. 
 
                      Table 1. Characteristics of respondent’s spirometry test and salivary MMP-9 activity  
Variables n Mean (SD) 
FEV1 (L) 30 1.67 (0.12) 
FVC (L) 30 2.97 (0.43) 
FEV1/FVC ratio (%) 30 56.15 (8.43) 
Salivary MMP-9 activity (PM) 30 1.85 (1.54)  
3.2. Correlation between FEV1, FVC, FEV1/FVC ratio and the salivary MMP-9 activity  
The salivary MMP-9 activity was correlated with spirometry tests by using Pearson correlation test. All 
spirometry values showed lower correlation towards the salivary MMP-9 activity with insignificant p values 
(p>0.05) as shown in Table 2. The pulmonary function tests might not conclude predicted enzyme activity of MMP-
9. 
 
                  Table 2. Correlation of FEV1, FVC, and FEV1/FVC ratio towards salivary MMP-9 activity 
Salivary MMP-9 activity 
r p value 
FEV1 (L) 0.119  0.532  
FVC (L) 0.018  0.923  
FEV1/FVC ratio (%) 0.161  0.396  
 
3.3. Discussion 
Smokers with COPD underwent a decrease in FEV1 and FVC, faster than non smokers, and so did the age 
accelerating the decrease concurrently. FEV1/FVC ratio is one of the considerations to initially recognize the 
obstructive diseases to determine whether COPD-suspected patients should be treated as suffering from obstructive 
lung disease or not. The estimated value of FEV1/FVC ratio should be confirmed and determined more 
appropriately3,4,9. Our study revealed spirometry results accordingly to diagnose COPD accurately (Table 1). 
Inflammatory progression on respiratory tracts, induced by smoking exposure, led to the release of numerous 
inflammatory cells predominantly neutrophils and macrophages that subsequently generated MMP-9. Release of 
MMP-9 was also led by some cytokines and oxidative stress. Beside increased level of MMP-9, the balance between 
MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 also influenced the degradation since TIMP-1 was the 
main anti protease maintaining the balance with MMP-9 in order to prevent action of active MMP-9. According to 
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spirometry values, the decline of FEV1 was linear with obstruction of airway caused by breakage of lung 
extracellular matrix (ECM)4,10. 
From periodontal tissue, periodontitis had more activity of protease, particularly MMP-9, released by neutrophils 
and fibroblasts together with some cytokines e.g. IL-6 and IL-10. Similar to what occured in lung tissues, increased 
activity of MMP-9 and MMP-9/TIMP-1 ratio would destruct extracellular matrix which finally caused 
periodontitis11,12,13. 
This study analyzed the salivary MMP-9 activity as the saliva was easily collected with a simple procedure. 
Previous studies have assessed the level and activity of MMP-9 from various body fluids, mostly sputum, 
bronchoalveolar lavage (BAL) and blood serum5,6,7. Increased activity of MMP-9 may cleave ECM of lung tissues. 
Normally, those suffering from COPD, with lower FEV1 and FEV1/FVC ratio <70%, would also exhibit the 
increased level and activity of MMP-9. However, the activity assessment was more appropriate as such activity 
might represent the breakage of ECM than might the level of MMP-9. Instead of both pro MMP-9 and bond MMP-
9, the activity only measured active MMP-914. 
The tide of MMP-9 activity apparently showed a dynamic sequence. Healthy smokers would exhibit MMP-9 
activity which was insignificant as compared to smokers with COPD. Prolonged smoking exposure was supposed to 
be responsible upon MMP-9 activity. Moreover, TIMP-1 also appeared to maintain the balance. Increased activity of 
MMP-9 corresponded with the airway obstruction and the destruction of the extracellular matrix among COPD 
patients. Moreover, the airway obstruction occured along with the increase of MMP-9/TIMP-1 ratio9. 
Spirometry also displayed dynamic values of pulmonary function test among COPD patients and so did MMP-9 
activity. Our study was initialized with determining correlation between spirometry value and MMP-9 activity. 
Unfortunately, FEV1, FVC, and FEV1/FVC ratio correlated poorly and was insignificant (p>0.05) with salivary 
MMP-9 activity (Table 2). The protease activity of MMP-9 apparently had its individual characteristics despite its 
dynamical sequence. Smoke, mostly from cigarettes, entered through the oral cavity. This smoke, then, went into 
lungs, yet the saliva was apparent to correspond better to the processes of the oral cavity diseases12,13. The genetic 
factor was supposed to affect the variability of MMP-9 activity among COPD respondents. The genetic 
susceptibility would be responsible to express response of MMP-9 activity towards exposures, particularly smoking 
exposure. In addition, role of TIMP-1 also facilitated the feedback toward MMP-9 activity15. 
Due to inadequately comparable results of spirometry values towards salivary MMP-9 activity, this study 
proposed to discover other MMP-9 activities from related biological samples. In this regards, we might suggest 
further evaluation on MMP-9 activity from sputum (preferably) and BAL. Then, various activities of MMP-9 would 
be compared to each other. The results would be valuable to estimate degradation of ECM from lung parenchyma 
among COPD patients derived from some associated biological fluids5,6,7. 
4. Conclusions 
Since FEV1, FVC, and FEV1/FVC ratio showed insignificant p value towards the salivary MMP-9 activity 
(p>0.05), pulmonary function tests apparently were poorly correlated with the salivary MMP-9 activity despite the 
similar exposure, i.e. smoking. In the future, similar studies should deepen included criteria for those suitably gained 
from many phenotypes of COPD patients in order to assess and estimate destruction of lung parenchyma caused by 
increased activity of MMP-9 in accord with spirometryಬs FEV1, FVC, and FEV1/FVC ratio. 
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